Is Grey Matters Health Inc. (GREY.CN) a Buy, Sell, or Hold?
CNQ : GREY.CN
Grey Matters Health Inc.
$0.35 CAD
-$0.01 (-4.11%)
- Volume
- 36.14K
- Average Volume
- 16.84K
- Market Capitalization
- $1.9M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $0.90
- Year Low
- $0.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
CNQ
Christopher J. Moreau
Biotechnology
Healthcare
GREY.CN
5
CA
CAD
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
No key metrics data available.
Company Executives
| Name | Title |
|---|---|
| Christopher Bryan | Vice President of Research & Operations |
| Christopher J. Moreau | CEO & Director |
| James F. Kinley | CFO & Corporate Secretary |
| Paul Moreau | Chief Marketing & Communications Officer |
Poll Results
No votes yet today — be the first to share your view!
About Grey Matters Health Inc. (CNQ:GREY.CN) Stock
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. ...
Jeff Bezos's Blue Origin reaches for starts with $10bn funding round at a $130bn valuation
2026-07-13 04:01:00
Blue Origin, the space company founded by Jeff Bezos, is raising $10 billion in its first funding round from outside investors. The deal values the business...
Deutsche Bank sees limited evidence AI is driving broad US job losses
2026-07-06 11:13:00
There is still limited evidence artificial intelligence is having a broad negative impact on the U.S. labor market, although some early trends suggest AI...
Frequently Asked Questions
-
What is the current Grey Matters Health Inc. (GREY.CN) stock price?
-
Grey Matters Health Inc.(CNQ:GREY.CN) stock price is $0.35 in the last trading session. During the trading session, GREY.CN stock reached the peak price of $0.9 while $0.335 was the lowest point it dropped to. The percentage change in GREY.CN stock occurred in the recent session was --4.11% while the dollar amount for the price change in GREY.CN stock was -$0.01.
-
GREY.CN's industry and sector of operation?
-
The CNQ listed GREY.CN is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of GREY.CN?
-
Christopher Bryan | Vice President of Research & Operations
Christopher J. Moreau | CEO & Director
James F. Kinley | CFO & Corporate Secretary
Paul Moreau | Chief Marketing & Communications Officer
| -
How many employees does GREY.CN have?
-
Number of GREY.CN employees currently stands at 5. GREY.CN operates from 601 West Broadway, Vancouver, BC V5Z 4C2, CA.
-
Link for GREY.CN official website?
-
Official Website of GREY.CN is: https://www.greymatters-health.com
-
How do I contact GREY.CN?
-
GREY.CN could be contacted at phone #+1 604 398 4175 and can also be accessed through its website. GREY.CN operates from 601 West Broadway, Vancouver, BC V5Z 4C2, CA.
-
How many shares of GREY.CN are traded daily?
-
The average number of GREY.CN shares traded daily for last 3 months was 16.84K.
-
What is the market cap of GREY.CN currently?
-
The market value of GREY.CN currently stands at $1.9M with its latest stock price at $0.35